Follow-The-Filings

Security · featured owners

LXEO Lexeo Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.3%
  • $2M

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel 0.33%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.33% Hold 377,059 $2M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$66.39M -$98.33M -$99.96M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $124.29M $126.12M $188.39M
Total non-current assets * $15.51M $20.82M $80.3M
Total assets $139.81M $146.94M $268.69M
Total current liabilities $17.24M $22.85M $16.81M
Total non-current liabilities * $9.03M $7.25M $5.21M
Total equity $113.54M $116.84M $246.67M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$59.5M -$81.15M -$98.56M
Cash from investing -$0.165M -$94.08M -$90.25M
Cash from financing $103.79M $88.78M $216.8M
Net change in cash $44.13M -$86.45M $27.98M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders